Surgical Periodontal Therapy with Recombinant Human Fibroblast Growth Factor-2 in Treatment of Chronic Periodontitis: A Case Report with 2-year Follow-up
- PMID: 33994424
- DOI: 10.2209/tdcpublication.2020-0045
Surgical Periodontal Therapy with Recombinant Human Fibroblast Growth Factor-2 in Treatment of Chronic Periodontitis: A Case Report with 2-year Follow-up
Abstract
We report a case of generalized chronic periodontitis requiring periodontal regenerative therapy. The patient was a 53-year-old woman who presented with the chief complaint of gingival swelling. An initial examination revealed 31.5% of sites with a probing depth of ≥4 mm and 46.3% with bleeding on probing. Radiographic examination showed vertical bone resorption in tooth #33. Horizontal adsorption was also observed in other areas. Based on a clinical diagnosis of severe generalized chronic periodontitis, initial periodontal therapy consisting of plaque control, scaling and root planing, occlusal adjustment, caries treatment, and splint placement was performed. After re-evaluation, surgical periodontal treatment was performed at selected sites. Periodontal regeneration therapy with recombinant human fibroblast growth factor (rhFGF)-2 was performed at #33. Two other sites (#14, 15), which had residual periodontal pockets, were treated by open-flap debridement. After re-evaluation, the patient was placed on a maintenance program. Periodontal regenerative therapy with rhFGF-2 resulted in an improvement in angular bone resorption, which has been properly maintained for 2 years. Continued care is needed to maintain stable periodontal conditions.
Keywords: Intrabony defects; Periodontal regenerative therapy; Recombinant human fibroblast growth factor-2.
Similar articles
-
Treatment of Chronic Periodontitis with Periodontal Surgery Including Regenerative Therapy Using Recombinant Human Fibroblast Growth Factor-2 and Papilla Preservation Technique: A Case Report with a Two-year Follow-up.Bull Tokyo Dent Coll. 2022 Jun 15;63(2):95-103. doi: 10.2209/tdcpublication.2021-0048. Epub 2022 May 25. Bull Tokyo Dent Coll. 2022. PMID: 35613866
-
Periodontal Regenerative Therapy with Recombinant Human Fibroblast Growth Factor-2 and Deproteinized Bovine Bone Mineral in Patient with Chronic Periodontitis: An 18-month Follow-up Report.Bull Tokyo Dent Coll. 2021 Jun 4;62(2):107-117. doi: 10.2209/tdcpublication.2020-0034. Epub 2021 May 14. Bull Tokyo Dent Coll. 2021. PMID: 33994421
-
Periodontal Regenerative Therapy with Enamel Matrix Derivative and Autogenous Bone Graft in Patient with Chronic Periodontitis: An 18-month Follow-up Report.Bull Tokyo Dent Coll. 2020 Mar 12;61(1):43-51. doi: 10.2209/tdcpublication.2019-0007. Epub 2020 Feb 20. Bull Tokyo Dent Coll. 2020. PMID: 32074587
-
Periodontal regeneration - intrabony defects: a consensus report from the AAP Regeneration Workshop.J Periodontol. 2015 Feb;86(2 Suppl):S105-7. doi: 10.1902/jop.2015.140378. Epub 2014 Oct 15. J Periodontol. 2015. PMID: 25315019
-
An insight into the possibilities of fibroblast growth factor in periodontal regeneration.J Indian Soc Periodontol. 2014 May;18(3):289-92. doi: 10.4103/0972-124X.134560. J Indian Soc Periodontol. 2014. PMID: 25024539 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources